Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The physiological relevance of downstream effectors of p53 activity.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

The combination of <i>EWSR1-FLI1</i> and loss of one <i>EWSR1</i> allele leads to the induction of trisomy 8.

bioRxiv : the preprint server for biology·2026

Same author

Clinical Characteristics and Cancer Histories Among Breast Cancer Patients With Li-Fraumeni Syndrome From a Single Institution.

Clinical breast cancer·2026

Same author

MDM4 at the Crossroads: Beyond p53 and MDM2.

Cancers·2026

Same author

Elucidating cooperative genetic events in DCIS progression in mutant <i>p53</i>-driven breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

A comparison of poly(methyl methacrylate) and silorane-based cements as carriers for local doxorubicin delivery.

Journal of materials science. Materials in medicine·2025

Same journal

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Molecular cancer research : MCR·2026

Same journal

Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities.

Molecular cancer research : MCR·2026

Same journal

CELF2 is a tumor suppressor that modulates SLC7A11 and promotes ferroptosis in stomach adenocarcinoma.

Molecular cancer research : MCR·2026

Same journal

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Molecular cancer research : MCR·2026

Same journal

Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

Molecular cancer research : MCR·2026

Same journal

Mapping the Subtype-Specific PARP1 ADP-ribosylated Proteome in Breast Cancer Cells.

Molecular cancer research : MCR·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 18, 2025

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

MDM2, an introduction.

Tomoo Iwakuma¹, Guillermina Lozano

¹Section of Cancer Genetics, Department of Molecular Genetics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Molecular Cancer Research : MCR

|January 7, 2004

Summary

This summary is machine-generated.

The murine double minute 2 (MDM2) protein regulates the p53 tumor suppressor. Increased MDM2 levels inactivate p53, promoting tumor growth, but MDM2 also interacts with other proteins like ARF.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

Related Experiment Videos

Last Updated: Dec 18, 2025

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation

Published on: March 9, 2018

Area of Science:

Molecular Biology
Oncology
Biochemistry

Background:

The murine double minute 2 (mdm2) gene is a key negative regulator of the p53 tumor suppressor.
Amplification or overexpression of mdm2 is observed in numerous cancers, leading to p53 inactivation.
p53 inactivation, via mdm2 or direct mutation/deletion, is a common event in tumor development.

Purpose of the Study:

To introduce the structure and biological functions of MDM2.
To explore the relationship between MDM2 and its binding partners, particularly p53 and ARF.
To discuss MDM2 functions independent of p53.

Main Methods:

Literature review and synthesis of existing research on MDM2.
Analysis of MDM2's role as an E3 ubiquitin ligase.
Examination of protein-protein interactions involving MDM2.

Main Results:

MDM2 targets p53 for degradation via its E3 ubiquitin ligase activity.
MDM2 binding to ARF sequesters MDM2 in the nucleolus, thereby activating p53.
Numerous other MDM2-interacting proteins and p53-independent functions have been identified.

Conclusions:

MDM2 plays a critical role in cancer development by regulating p53.
Understanding MDM2's interactions and functions is crucial for cancer research.
Further investigation into MDM2's diverse roles may reveal new therapeutic strategies.